Cargando…
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments
Renal medullary carcinoma (RMC) is a rare, aggressive disease that predominantly afflicts individuals of African or Mediterranean descent with sickle cell trait. RMC comprises 1% of all renal cell carcinoma diagnoses with a median overall survival of 13 months. Patients are typically young (median a...
Autores principales: | Wei, Darmood, Yang, Youfeng, Ricketts, Christopher J., Vocke, Cathy D., Ball, Mark W., Sourbier, Carole, Wangsa, Darawalee, Wangsa, Danny, Guha, Rajarshi, Zhang, Xiaohu, Wilson, Kelli, Chen, Lu, Meltzer, Paul S., Ried, Thomas, Thomas, Craig J., Merino, Maria J., Linehan, W. Marston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383978/ https://www.ncbi.nlm.nih.gov/pubmed/32259323 http://dx.doi.org/10.1002/gcc.22847 |
Ejemplares similares
-
Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines
por: Yang, Youfeng, et al.
Publicado: (2021) -
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
por: Lang, Martin, et al.
Publicado: (2023) -
Concurrent V(D)J recombination and DNA end instability increase interchromosomal trans-rearrangements in ATM-deficient thymocytes
por: Bowen, Steven, et al.
Publicado: (2013) -
Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers
por: Sourbier, Carole, et al.
Publicado: (2018) -
A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug
por: Chen, Chen, et al.
Publicado: (2017)